Total30 multifocal for astigmatism, a monthly toric lens for patients with presbyopia, is now available in the U.S., ...
In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results